Record capital flows across global public and private markets has opened up new channels of investment in early-stage and novel science.
James Leech
Advertisement
Articles by James Leech
Advertisement
Latest Updated Articles
Cross-Border Funding in the Life SciencesPublished: August 21st 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
2
Alkermes plc Acquiring Avadel Pharmaceuticals in $2.1 Billion Definitive Agreement
3
Roundup: Pharma Industry Raises Funding Aimed at Advancing the Development and Testing of Rare Disease Treatments
4
Moderna Ceases Development of mRNA-1647 After Failing to Reach Primary Goal in Clinical Trial
5
